AGP Executive Report
Last update: 12 hours agoTexas Hemp Crackdown: The Texas Supreme Court ruled manufactured hemp THC products like delta-8, delta-10 and THCP are controlled substances, raising the stakes for shoppers and sellers who relied on the 2018 Farm Bill loophole. Youth & Public Health: A new JAMA Psychiatry study links rising cannabis use in the US to higher cannabis use disorder symptoms, with about 30% of users showing signs of the condition. Vape Safety Push: Ireland’s HSE says high-risk synthetic cannabinoids were found in vapes and edibles, urging stronger regulation after mislabeling concerns. Court & Enforcement: A UK gang of 11 couriers was convicted for smuggling £13.8m of cannabis through Birmingham Airport, while police in Phoenix seized drugs worth about R1.07m in an intelligence-led operation. Local Policy & Access: Berkeley’s Cannabis Trail and Visit Berkeley are spotlighting long-running medical cannabis support groups, as the city looks to bring back on-site consumption for patients. Business Watch: Australia’s listed cannabis stocks saw mixed signals, with Vitura Health posting record profit while Cann Group flagged going-concern uncertainty.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Cannabis-Based Oil Fails to Improve Pain or Nonmotor Symptoms in Parkinson Disease Study]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/27693930-935721615-b237f6d5ccd92206f92128a11b3721457ba9ddb7-1950x1021-200x105.png)
Pseudo-journalism: Pink-slime
